Joanna Hester

10PUBLICATIONS
76CO-AUTHORS
Predictive and prognostic markersEpigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Transplantation immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 22, 2026
IRE1 activity is prognostic in localised and metastatic prostate cancer and affects epithelial lineage states.

|Aug 12, 2026
Epigenetic modulation of stromal cell states underpins pathological tissue niches in Crohn's disease.

|Oct 13, 2025
HLA matching or CRISPR editing of HLA class I/II enables engraftment and effective function of allogeneic human regulatory T cell therapy in a humanized mouse transplantation model.

Oliver McCallion, Weijie Du, Viktor Glaser

|Oct 22, 2024
A longitudinal single-cell atlas of anti-tumour necrosis factor treatment in inflammatory bowel disease.

Tom Thomas, Matthias Friedrich, Charlotte Rich-Griffin

|Sep 15, 2024
Regulatory cell therapy for kidney transplantation and autoimmune kidney diseases.

Quan Yao Ho, Joanna Hester, Fadi Issa

|Jun 06, 2022
Ex vivo-expanded human CD19+TIM-1+ regulatory B cells suppress immune responses in vivo and are dependent upon the TIM-1/STAT3 axis.

S Shankar, J Stolp, S C Juvet

Pageof 2

Frequent Collaborators

9 joint publications

Fadi Issa

2 joint publications

Sushma Shankar

2 joint publications

Calliope Dendrou

2 joint publications

Simon Travis